DCF Advisers »

Alnylam Pharmaceuticals shares owned by DCF Advisers

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by DCF Advisers

Quarter filed Position value Share count Share price at filing
2023-09-30 $319k 1.8k 177.10
2023-06-30 $304k 1.6k 189.94
2023-03-31 $280k 1.4k 200.32
2022-12-31 $333k 1.4k 237.65
2022-09-30 $280k 1.4k 200.00
2022-06-30 $729k 5.0k 145.80
2022-03-31 $3.1M 19k 163.32
2021-12-31 $3.1M 18k 169.56
2021-09-30 $3.3M 18k 188.80
2021-06-30 $3.0M 18k 169.54
2021-03-31 $2.8M 20k 141.20
2020-12-31 $2.6M 20k 129.95
2020-09-30 $4.0M 28k 145.60
2020-06-30 $4.1M 28k 148.11
2020-03-31 $3.2M 29k 108.86
2019-12-31 $4.6M 40k 115.18